{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:07:42Z","timestamp":1747206462966,"version":"3.40.5"},"reference-count":22,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s416307","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:20:29Z","timestamp":1697775629000},"page":"3529-3543","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Neel","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Slatkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-0722","authenticated-orcid":true,"given":"Nancy","family":"Stambler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3611-8628","authenticated-orcid":true,"given":"Eric","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/AJP.0000000000000852","volume":"36","author":"Argoff","year":"2020","journal-title":"Clin J Pain"},{"key":"ref2","first-page":"S4","volume":"64","author":"Johnson","year":"2015","journal-title":"J Fam Pract"},{"key":"ref3","first-page":"1","volume":"21","author":"Rogers","year":"2013","journal-title":"Clin Geriatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","volume":"61","author":"Panchal","year":"2007","journal-title":"Int J Clin Pract"},{"key":"ref5","first-page":"44","volume":"19","author":"Iyer","year":"2010","journal-title":"Manag Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"ref7","unstructured":"Relistor (methylnaltrexone bromide) prescribing information; 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021964s019,208271s003lbl.pdf. Accessed: September 12, 2023."},{"key":"ref8","first-page":"39","volume":"7","author":"Slatkin","year":"2009","journal-title":"J Support Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jpm.2014.0362","volume":"18","author":"Bull","year":"2015","journal-title":"J Palliat Med"},{"key":"ref11","unstructured":"ECOG performance status scale; 2022. Available from: https:\/\/ecog-acrin.org\/resources\/ecog-performance-status. Accessed August 11, 2023."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jpain.2010.11.008","volume":"12","author":"Michna","year":"2011","journal-title":"J Pain"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jpainsymman.2011.02.015","volume":"42","author":"Slatkin","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40266-016-0381-2","volume":"33","author":"Chokhavatia","year":"2016","journal-title":"Drugs Aging"},{"key":"ref15","unstructured":"Movantik (naloxegol) prescribing information. Wilmington, DE: AstraZeneca Pharmaceuticals; 2020."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e17825","DOI":"10.1097\/MD.0000000000017825","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","volume":"182","author":"Pappagallo","year":"2001","journal-title":"Am J Surg"},{"key":"ref19","first-page":"149","volume":"8","author":"Wickham","year":"2017","journal-title":"J Adv Pract Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/141737","volume":"2014","author":"Kumar","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.cgh.2018.01.021","volume":"16","author":"Nee","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.2147\/JPR.S312731","volume":"14","author":"Chamberlain","year":"2021","journal-title":"J Pain Res"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93621","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93621","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:20:36Z","timestamp":1697775636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/impact-of-patient-subgroups-on-the-efficacy-and-safety-of-methylnaltre-peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2147\/jpr.s416307","relation":{},"ISSN":["1178-7090"],"issn-type":[{"type":"electronic","value":"1178-7090"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}